Frontlight ResearchEarly access
Trial site
M2M Med. Badania Sp. z o.o.
- 10running trials
- 2closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)2 trials
- Bronchiectasis2 trials
- Crohn's disease2 trials
- Type 2 diabetes2 trials
- Atrial fibrillation1 trial
- Chronic kidney disease1 trial
- Chronic spontaneous urticaria1 trial
- Rheumatoid arthritis1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 39 trials
- Phase 22 trials
- Phase 11 trial
- Status
- Recruiting4 trials
- Active, not recruiting3 trials
- Not yet recruiting3 trials
- Completed1 trial
- Withdrawn1 trial
- Lead sponsor
- Boehringer Ingelheim2 trials
- Janssen Research & Development, LLC2 trials
- Novo Nordisk A/S2 trials
- Pfizer2 trials
- Merck Sharp & Dohme LLC1 trial
- and 3 more
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Recruiting
Recruiting
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Recruiting
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
Recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes2 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Bronchiectasis1 recruiting
- Chronic kidney disease1 recruiting
- Chronic spontaneous urticaria1 recruiting
- Crohn's disease1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Recruiting
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026